Published in Eur J Clin Microbiol Infect Dis on January 08, 2004
Identification of blood and wound isolates of C. canimorsus and C. cynodegmi using VITEK2 and MALDI-TOF. Eur J Clin Microbiol Infect Dis (2012) 1.25
Capnocytophaga sputigena bacteremia in a patient with chronic lymphocytic leukemia. Ann Lab Med (2014) 0.77
Capnocytophaga species: infections in nonimmunocompromised and immunocompromised hosts. J Infect Dis (1985) 2.21
Capnocytophaga bacteremia in a patient with Hodgkin's disease following bone marrow transplantation: case report and review. Clin Infect Dis (1992) 1.81
Bacteremia by multidrug-resistant Capnocytophaga sputigena. J Clin Microbiol (1994) 1.17
A series of infections due to Capnocytophaga spp in immunosuppressed and immunocompetent patients. Clin Microbiol Infect (2003) 1.12
Bacteremia caused by Capnocytophaga species in patients with neutropenia and cancer: results of a multicenter study. Clin Infect Dis (2001) 0.87
Vertebral osteomyelitis due to Capnocytophaga species in immunocompetent patients: report of two cases and review. Clin Infect Dis (1996) 0.84
[Septicemia caused by Capnocytophaga sputigena]. Nouv Presse Med (1981) 0.82
Capnocytophaga sputigena bacteremia associated with acute leukemia. Kansenshogaku Zasshi (1993) 0.81
[Aortic endocarditis due to Capnocytophaga sputigena]. Med Clin (Barc) (1995) 0.78
[Initial antibacterial prophylaxis after bone marrow allograft. Pilot study with systemic vancomycin]. Pathol Biol (Paris) (1988) 0.75
[Bacteremia due to Capnocytophaga spp.: two cases]. Enferm Infecc Microbiol Clin (2003) 0.75
[Capnocytophaga sputigena in sinusitis]. Acta Otorhinolaryngol Belg (1983) 0.75
[Capnocytophaga septicemia during bone marrow transplantation. Apropos of 2 cases]. Ann Pediatr (Paris) (1990) 0.75
[Capnocytophaga spp. bacteremia in compromised patients]. Enferm Infecc Microbiol Clin (1993) 0.75
Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature (1999) 12.95
Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med (2000) 8.89
Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J Neurosci (1997) 2.91
Clinical spectrum of urinary tract infections due on nontyphoidal Salmonella species. Clin Infect Dis (1996) 2.33
Corynebacterium group D2 as a cause of alkaline-encrusted cystitis: report of four cases and characterization of the organisms. J Clin Microbiol (1985) 2.01
Cutaneous tuberculosis: a clinical, histopathologic, and bacteriologic study. J Am Acad Dermatol (1995) 1.90
Carcinomas with metaplasia and sarcomas of the breast. Am J Clin Pathol (1991) 1.89
Location of the serine residue involved in the linkage between the terminal protein and the DNA of phage phi 29. Nucleic Acids Res (1985) 1.68
Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Heart (2003) 1.55
In vitro and in vivo study of stone formation by Corynebacterium group D2 (Corynebacterium urealyticum). J Clin Microbiol (1986) 1.54
Antimicrobial susceptibility of Corynebacterium group D2. Antimicrob Agents Chemother (1985) 1.54
Flow cytometry and the study of central nervous disease in patients with acute leukaemia. Br J Haematol (2001) 1.52
Primary structure and inhibition of protein synthesis in eukaryotic cell-free system of a novel thionin, gamma-hordothionin, from barley endosperm. Eur J Biochem (1990) 1.49
Monocytoid B-cell lymphoma. Am J Surg Pathol (1989) 1.47
A case of Hirayama disease treated with laminectomy and duraplasty without spinal fusion. Neurocirugia (Astur) (2009) 1.47
Effects of whole-body vibration and resistance training on knee extensors muscular performance. Eur J Appl Physiol (2011) 1.47
[Soft-tissue infection caused by Aeromonas hydrophila]. Enferm Infecc Microbiol Clin (1995) 1.46
European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing. Clin Microbiol Infect (2006) 1.45
Evaluation of API Coryne system for identifying coryneform bacteria. J Clin Pathol (1994) 1.44
[Idiopathic thrombocytopenic purpura in 5 members of a family]. Sangre (Barc) (1994) 1.39
Improved direct epifluorescent filter technique for rapid bioburden control in intravenous solutions. J Parenter Sci Technol (1992) 1.38
Activity of nine antimicrobial agents against Corynebacterium group D2 strains isolated from clinical specimens and skin. Antimicrob Agents Chemother (1987) 1.33
Travel-related imported infections in Europe, EuroTravNet 2009. Clin Microbiol Infect (2011) 1.23
Classification of coryneform bacteria associated with human urinary tract infection (group D2) as Corynebacterium urealyticum sp. nov. Int J Syst Bacteriol (1992) 1.20
Isolation of Propionibacterium acnes from central nervous system infections. Anaerobe (1995) 1.18
Bacteriuria with a multiply resistant species of Corynebacterium (Corynebacterium group D2): an unnoticed cause of urinary tract infection. J Infect Dis (1987) 1.16
Pneumonia after lung transplantation in the RESITRA Cohort: a multicenter prospective study. Am J Transplant (2007) 1.11
Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction. J Steroid Biochem Mol Biol (1996) 1.11
Bronchoscopic balloon dilatation in the management of bronchial stenosis following lung transplantation. Respir Med (2006) 1.10
Intravascular ultrasound of the elastic pulmonary arteries: a new approach for the evaluation of primary pulmonary hypertension. Heart (2003) 1.08
Measurement of biofilm formation by clinical isolates of Escherichia coli is method-dependent. J Appl Microbiol (2008) 1.07
Distribution and properties of major ribosome-inactivating proteins (28 S rRNA N-glycosidases) of the plant Saponaria officinalis L. (Caryophyllaceae). Biochim Biophys Acta (1993) 1.07
Bordetella hinzii, a "new" opportunistic pathogen to think about. J Infect (2000) 1.05
Simian virus 40 in a human cancer. Nature (1974) 1.05
Complete amino acid sequence of the Aspergillus cytotoxin mitogillin. Biochemistry (1985) 1.03
NFkappaB1 (p50)-deficient mice are not susceptible to multiple low-dose streptozotocin-induced diabetes. J Endocrinol (2002) 1.02
Analysis of the activation process of porcine procarboxypeptidase B and determination of the sequence of its activation segment. Biochemistry (1991) 1.02
Primary structure of the activation segment of procarboxypeptidase A from porcine pancreas. Biochem Biophys Res Commun (1986) 1.00
Q fever endocarditis on porcine bioprosthetic valves. Clinicopathologic features and microbiologic findings in three patients treated with doxycycline, cotrimoxazole, and valve replacement. Ann Intern Med (1988) 1.00
In vitro susceptibilities of rapidly growing mycobacteria to telithromycin (HMR 3647) and seven other antimicrobials. Antimicrob Agents Chemother (2000) 1.00
Aortic endocarditis caused by gentamicin-resistant Enterococcus faecalis. Eur J Clin Microbiol Infect Dis (1988) 1.00
Increasing incidence of Corynebacterium group D2 strains resistant to norfloxacin and ciprofloxacin. Eur J Clin Microbiol Infect Dis (1989) 1.00
Liver mitochondrial dysfunction and oxidative stress in the pathogenesis of experimental nonalcoholic fatty liver disease. Braz J Med Biol Res (2006) 0.99
Bioelectrical impedance vector analysis in haemodialysis patients: relation between oedema and mortality. Physiol Meas (2004) 0.99
Role of endogenous sulphydryls and neutrophil infiltration in the pathogenesis of gastric mucosal injury induced by piroxicam in rats. Inflamm Res (1996) 0.98
Infection caused by the nonfermentative gram-negative bacillus CDC group IV c-2: case report and literature review. Eur J Clin Microbiol Infect Dis (1993) 0.97
Bactericidal activity of chloramphenicol, clindamycin, metronidazole and cefoxitin against Bacteroides fragilis. J Antimicrob Chemother (1980) 0.96
Development of experimental pneumonia by infection with penicillin-insensitive Streptococcus pneumoniae in guinea pigs and their treatment with amoxicillin, cefotaxime, and meropenem. Antimicrob Agents Chemother (1996) 0.96
Bacteroides fragilis resistant to clindamycin. J Antimicrob Chemother (1981) 0.96
In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria. Antimicrob Agents Chemother (2008) 0.96
Peritonitis with CDC group IVc-2 bacteria in a patient on continuous ambulatory peritoneal dialysis. Eur J Clin Microbiol Infect Dis (1991) 0.95
Six cases in which mesenteric lymphadenitis due to non-typhi Salmonella caused an appendicitis-like syndrome. Clin Infect Dis (1995) 0.95
Search for perinatal viral infection. A prospective, clinical, virologic, and serologic study. Am J Dis Child (1968) 0.95
High rates of erythromycin-resistant Streptococcus pneumoniae among penicillin-resistant strains. J Antimicrob Chemother (1993) 0.94
Isolation of Corynebacterium ureicelerivorans from normally sterile sites in humans. Eur J Clin Microbiol Infect Dis (2008) 0.93
The susceptibility of Yersinia to eleven antimicrobials. J Antimicrob Chemother (1982) 0.93
[Bacteremia caused by Alcaligenes (Achromobacter) xylosoxidans. Description of 3 cases and review of the literature]. Enferm Infecc Microbiol Clin (1997) 0.93
Effect of pH and buffer system on the in-vitro activity of five antifungals against yeasts. J Antimicrob Chemother (1997) 0.93
Transmission permeability of tuberculosis involving immigrants, revealed by a multicentre analysis of clusters. Clin Microbiol Infect (2009) 0.93
Changes in susceptibility of Salmonella enteritidis, Salmonella typhimurium, and Salmonella virchow to six antimicrobial agents in a Spanish hospital, 1980-1994. Eur J Clin Microbiol Infect Dis (1996) 0.92
Surgical wound infections due to Propionibacterium acnes: a study of 10 cases. J Hosp Infect (1995) 0.92
Failure of Gram stain to detect Propionibacterium acnes in specimens from clinically significant infections. J Clin Microbiol (1996) 0.92
Purification and properties of five different forms of human procarboxypeptidases. Eur J Biochem (1989) 0.92
Microbiological characterization and clinical significance of Corynebacterium amycolatum strains. Eur J Clin Microbiol Infect Dis (1999) 0.92
SPG7 mutational screening in spastic paraplegia patients supports a dominant effect for some mutations and a pathogenic role for p.A510V. Clin Genet (2012) 0.91
In vitro activity of tigecycline and 10 other antimicrobials against clinical isolates of the genus Corynebacterium. Int J Antimicrob Agents (2009) 0.91
Protein reverse staining: high-efficiency microanalysis of unmodified proteins detected on electrophoresis gels. Anal Biochem (1995) 0.91
Simple immunodiffusion test for detecting antibodies against Legionella pneumophila serotype 1. J Clin Microbiol (1982) 0.91
Antimicrobial susceptibility of Haemophilus influenzae, Haemophilus parainfluenzae and Moraxella catarrhalis isolated from adult patients with respiratory tract infections in four southern European countries. The ARISE project. Int J Antimicrob Agents (2004) 0.91
Donor-to-host transmission of bacterial and fungal infections in lung transplantation. Am J Transplant (2006) 0.90
Long interval between HCV infection and development of hepatocellular carcinoma. Liver (1995) 0.90
Pseudomonas species Ve-2 septicemia. Eur J Clin Microbiol (1986) 0.90
Clinical significance of primary vs. secondary bacteremia due to nontyphoid Salmonella in patients without AIDS. Clin Infect Dis (1994) 0.90
Meningitis caused by Alcaligenes (Achromobacter) xylosoxidans associated with epidural catheter. Infection (1996) 0.90
Hypokalemic periodic paralysis mutations: confirmation of mutation and analysis of founder effect. Neuromuscul Disord (1996) 0.90
Problems in minimum inhibitory concentration determinations in coryneform organisms. Comparison of an agar dilution and the Etest. Diagn Microbiol Infect Dis (1994) 0.90
Classifying extraintestinal non-typhoid Salmonella infections. QJM (1996) 0.90
[Osteoarticular infections by Salmonella non-typhi]. Enferm Infecc Microbiol Clin (1996) 0.89
Mycobacterium tuberculosis bacteremia in a university hospital. Int J Tuberc Lung Dis (2001) 0.89
Identification of three novel mutations in the gene for Cu/Zn superoxide dismutase in patients with familial amyotrophic lateral sclerosis. Neuromuscul Disord (1995) 0.89
Biofilm development by clinical strains of non-pigmented rapidly growing mycobacteria. Clin Microbiol Infect (2009) 0.89
Streptococcus pneumoniae endophthalmitis: a study of 36 cases with special reference to antibiotic resistance and treatment options. Clin Microbiol Infect (2006) 0.89
Emergence of urea-splitting multi-resistant coryneform bacteria (Corynebacterium group D2) as pathogens. Eur J Clin Microbiol (1987) 0.88
Neurodegenerative Alzheimer-like pathology in PDAPP 717V-->F transgenic mice. Prog Brain Res (1998) 0.88
In vitro activity of linezolid and 11 other antimicrobials against 566 clinical isolates and comparison between NCCLS microdilution and Etest methods. J Antimicrob Chemother (2001) 0.88
Cytopathic effect mimicking virus culture due to Mycobacterium tuberculosis. J Clin Microbiol (1993) 0.88
Effects of human serum albumin, ibuprofen and N-acetyl-L-cysteine against biofilm formation by pathogenic Escherichia coli strains. J Hosp Infect (2010) 0.88
Seroprevalence of varicella antibodies in healthcare workers and health sciences students. Reliability of self-reported history of varicella. Vaccine (2005) 0.88
Prevention and reduction of AD-type pathology in PDAPP mice immunized with A beta 1-42. Ann N Y Acad Sci (2000) 0.88
Molecular analysis of the superoxide dismutase 1 gene in Spanish patients with sporadic or familial amyotrophic lateral sclerosis. Muscle Nerve (2002) 0.87
The primary structure of the cytotoxin restrictocin. Eur J Biochem (1984) 0.87
Taxonomic implications of the chemical analysis of the D2 group of corynebacteria. FEMS Microbiol Lett (1990) 0.87
Pulmonary infection by Mycobacterium gordonae in an immunocompromised patient. Diagn Microbiol Infect Dis (1987) 0.86